These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25593038)

  • 1. Chronic inflammatory mediators enhance prostate cancer development and progression.
    Thapa D; Ghosh R
    Biochem Pharmacol; 2015 Mar; 94(2):53-62. PubMed ID: 25593038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.
    Gueron G; De Siervi A; Vazquez E
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):213-21. PubMed ID: 22183772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and chronic prostatic diseases: evidence for a link?
    Sciarra A; Di Silverio F; Salciccia S; Autran Gomez AM; Gentilucci A; Gentile V
    Eur Urol; 2007 Oct; 52(4):964-72. PubMed ID: 17618043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent role of inflammation in prostate diseases: chemoprevention development opportunity.
    Hamid AR; Umbas R; Mochtar CA
    Acta Med Indones; 2011 Jan; 43(1):59-65. PubMed ID: 21339547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of inflammation and prostate cancer.
    Platz EA; De Marzo AM
    J Urol; 2004 Feb; 171(2 Pt 2):S36-40. PubMed ID: 14713751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could inflammation be a key component in the progression of benign prostatic hyperplasia?
    Kramer G; Marberger M
    Curr Opin Urol; 2006 Jan; 16(1):25-9. PubMed ID: 16385197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between benign prostatic hyperplasia and inflammation.
    Bostanci Y; Kazzazi A; Momtahen S; Laze J; Djavan B
    Curr Opin Urol; 2013 Jan; 23(1):5-10. PubMed ID: 23159991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate growth and inflammation.
    Sciarra A; Mariotti G; Salciccia S; Autran Gomez A; Monti S; Toscano V; Di Silverio F
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):254-60. PubMed ID: 17935971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib.
    Narayanan NK; Nargi D; Horton L; Reddy BS; Bosland MC; Narayanan BA
    Prostate; 2009 Feb; 69(2):133-41. PubMed ID: 18819100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Knowledge of the Potential Links between Inflammation and Prostate Cancer.
    Cai T; Santi R; Tamanini I; Galli IC; Perletti G; Bjerklund Johansen TE; Nesi G
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and prostate cancer.
    Vasto S; Carruba G; Candore G; Italiano E; Di Bona D; Caruso C
    Future Oncol; 2008 Oct; 4(5):637-45. PubMed ID: 18922121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIM2, an IFN-inducible cytosolic DNA sensor, in the development of benign prostate hyperplasia and prostate cancer.
    Ponomareva L; Liu H; Duan X; Dickerson E; Shen H; Panchanathan R; Choubey D
    Mol Cancer Res; 2013 Oct; 11(10):1193-202. PubMed ID: 23864729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the intricate relationship between chronic inflammation and cancer.
    Chai EZ; Siveen KS; Shanmugam MK; Arfuso F; Sethi G
    Biochem J; 2015 May; 468(1):1-15. PubMed ID: 25940732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate carcinogenesis and inflammation: emerging insights.
    Palapattu GS; Sutcliffe S; Bastian PJ; Platz EA; De Marzo AM; Isaacs WB; Nelson WG
    Carcinogenesis; 2005 Jul; 26(7):1170-81. PubMed ID: 15498784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate inflammation and its potential impact on prostate cancer: a current review.
    Haverkamp J; Charbonneau B; Ratliff TL
    J Cell Biochem; 2008 Apr; 103(5):1344-53. PubMed ID: 17955503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: possible role in cancer progression.
    Housa D; Vernerova Z; Heracek J; Cechak P; Rosova B; Kuncova J; Haluzik M
    Neoplasma; 2008; 55(5):442-6. PubMed ID: 18665756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
    Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
    Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.